PT-141

PT-141

PT-141  is a synthetic peptide studied for its interaction with melanocortin receptors, particularly those involved in neurological signaling.

Unlike compounds that act directly on peripheral blood vessels, PT-141 has been investigated for its effects on central nervous system pathways.

Research Overview

PT-141 is studied in several areas of pharmacological research, including:

• Melanocortin receptor signaling: Investigation of receptor activation and downstream cellular responses.
• Neurobiology: Research into central nervous system signaling pathways.
• Receptor pharmacology: Examination of the relationship between melanocortin receptor activity and physiological responses.

Bremelanotide is also the active ingredient in an FDA-approved prescription medication for a specific indication. Ardentis Compounds' research material should not be represented as equivalent to that approved medication.

Product Specifications

• Compound: PT-141
• Labeled quantity: 10 mg
• Compound class: Synthetic melanocortin receptor agonist
• Presentation: Research peptide vial
• Intended use: Laboratory research only

Quality & Documentation

Review the product label and any available batch specific analytical documentation for information about identity, purity, and other tested attributes. Analytical testing does not establish sterility unless appropriate sterility testing has also been performed.

Research Use Disclaimer

For laboratory research use only. Not intended for human consumption, injection, clinical treatment, or veterinary use.

For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.